PIRAZOLSKI DERIVATI KAO MODULATORI KALCIJEVIH KANALA AKTIVIRANIH OSLOBAĐANJEM KALCIJA

• 收藏
• 分享

专利权人:

Rhizen Pharmaceuticals S.A.

发明人:

Muthuppalaniappan, Meyyappan,Viswanadha, Srikant,Merikapudi, Gayatri, Swaroop,Vakkalanka, Swaroop, Kumar, V.S.,Vakkalanka,

申请号：

HRP20181076

公开号：

HRP20181076T1

申请日:

2018.07.10

申请国别(地区):

HR

年份:

2018

代理人:

摘要：

Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/